United States v. Generix Drug Corp.’s Empirical Analysis

Citation profile

7 federal appellate · 1 district · 1 state decisions

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 10 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

1. “[201](g)(1) The term 'drug' means (A) articles recognized in the official United States Pharmacopeia, official Homoeopathic Pharmacopoeia of the United States, or official National Formulary, or any supplement to any of them; and (B) articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man or other animals; and (C) articles (other than food) intended to affect the structure or any function of the body of man or other animals; and (D) articles intended for use as a component of any article specified in clauses (A), (B), or (C) of this paragraph; but does not include devices or their components, parts, or accessories.”

   1 later decision quote this exact passage · from the majority
   e.g. United States v. Generix Drug Corp.

2. “any drug . . . [which] is not generally recognized as safe and effective . . . or . . . which has not, otherwise than in [safety and effectiveness] investigations, been used to a material extent or for a material time.”

   1 later decision quote this exact passage · from the majority
   e.g. United States v. Generix Drug Corp.

3. “Drug products which are bioequivalent can be used interchangeably for the treatment of the same illness.”

   1 later decision quote this exact passage · from the majority
   e.g. United States v. Baxter Healthcare Corp.